BX — Blackstone Inc.

The Street is constructive — consensus Buy, 19 Buy vs 10 Hold and 1 Sell, and a $145.89 consensus price target versus $128.51 on 2026-09-13 — and the operating news has been good (Q2 2026 EPS of $1.52 vs $1.34 expected, revenue up 35.9% YoY per the brief; FMP's figures show $4.769B revenue, +28.5% YoY, on its own definition, and diluted EPS of $1.57). But the tape is telling a different story: as of 2026-09-13 the stock was down 5.61% over one week and 12.23% over one month, RSI sat at 38.2, and price was below all three key moving averages. Good numbers plus a falling price means the market is de-rating the multiple (risk appetite, realization-timing skepticism), not marking down estimates — which is why sentiment lands in the middle rather than Bullish or Bearish.

Revenue is lumpy by nature — this is a firm that books carried interest when it exits investments — but the direction over the last three quarters is unambiguously up. From Q4 2024 through Q3 2025, quarterly revenue ranged $2.82B-$3.71B and YoY growth was negative in two of four quarters (Q1 2025 -6.7%, Q3 2025 -6.2%). Then the business inflected: Q4 2025 $4.36B (+54.7% YoY), Q1 2026 $4.10B (+39.3%), and a new high of Q2 2026 $4.77B (+28.5% YoY). TTM revenue is $16.04B, up 28.6% versus the prior TTM window; TTM net income of $3.52B is up 22.9%. Margins are expanding: Q2 2026 operating margin was 61.9% versus 51.6% in Q2 2025, with TTM operating margin at 52.1% and TTM net margin at 21.9%. Diluted EPS tells the same story: $0.80 in Q3 2025 → $1.30 in Q4 2025 → $0.83 in Q1 2026 → $1.57 in Q2 2026. One caveat worth flagging: revenue jumped ~160% quarter-over-quarter from Q4 2023 ($1.215B) to Q1 2024 ($3.157B), a discontinuity that makes older trend comparisons unreliable, and FMP's revenue/EPS definitions differ from the company's distributable-earnings framing used in the brief ($4.77B/$1.57 vs $5.04B/$1.52). Conclusion: this is a genuine re-acceleration driven by fee growth and deployment, not a one-quarter blip — but it is a realization-driven business, so the sequence will not be linear.

On earnings this is cheap versus its own history and roughly fair in absolute terms. As of 2026-09-13 the stock trades at 28.6x trailing EPS of $4.492 versus a 5-year average P/E of 40.88x — roughly a 30% discount to its own multiple history, though that 5-year average was set in a zero-rate era when alternative managers commanded inflated multiples. Forward P/E on next-FY consensus EPS of $5.944 is 21.6x, and PEG is 1.36 against a business that just grew revenue ~28% YoY and EPS 60% YoY — a defensible price for the growth. Price/sales is 9.68x vs a 5-year average of 9.25x, so on revenue it is not cheap, and price/book of 11.17x is not a useful anchor for an asset manager whose book equity ($9.0B) is a sliver of its earnings power. The 3.88% dividend yield is the real valuation support here. Verdict: fair-to-attractive on earnings, fairly priced on sales, and clearly not expensive relative to its own post-2021 history — which is why the deterministic model tags it 'Cheap vs. its own history.'

The key pattern to read: price is falling while earnings expectations are rising. The stock is down 12.2% in the month to 2026-09-13, yet consensus expects next-FY EPS of $5.944 versus $4.492 trailing — about 32% growth that has not yet been fully reported. Q2 2026's $1.57 diluted EPS annualizes above that consensus, so the current run-rate arguably supports the forward number if realization activity holds. What the market appears to be pricing is skepticism about the carried-interest leg: fee-related earnings are recurring, but performance fees depend on exits, and a frozen IPO/M&A window would push that $5.94 to the right. Net read: the multiple is compressed on fear about the timing of earnings, not the level of them — which creates an asymmetric setup if rate cuts reopen exit channels into 2027, and a value trap if they don't.

As of 2026-09-13, RSI(14) was 38.23 — weak, but not the sub-30 washout that usually marks a tradeable low. Price at $128.51 sat 7.5% below the 20-day (~$138.9), 3.8% below the 50-day (~$133.6), and 1.62% below the 200-day (~$130.6): below all three, with the 200-day just overhead. Returns were -5.61% over one week, -12.23% over one month, but still +4.66% over three months and +20.35% over six — i.e., the six-month uptrend is being tested at its long-term trend line, not yet broken. Entry-timing implication: this is not a knife-catch candidate. The 200-day near $130 is the line to watch — a reclaim on volume would signal the uptrend resuming, while a decisive loss opens the door toward the lower $110s and the 52-week low of $101.73. RSI below 30 would be the cleaner tactical entry; it isn't there yet.

• Easing global monetary policy and cooling inflation are lowering the cost of capital, which directly improves transaction velocity, corporate borrowing for portfolio companies, and the reopening of IPO/M&A exit channels that drive carried interest.
• The AI/data-center/power infrastructure capex super-cycle is a multi-year deployment opportunity across Blackstone's real estate, infrastructure, and credit platforms — and the firm has been explicit about leaning into it.
• Private credit expansion as traditional banks retrench is a structural tailwind for the credit and insurance segment, though compressed credit spreads cap the economics on new originations.
• Commercial real estate recovery remains uneven: falling rates help valuations and refinancing, but office and other impaired sub-sectors continue to slow realizations and carry impairment risk.
• Blackstone's beta of 1.558 makes the stock a high-torque proxy for risk appetite — which is why the multiple is compressing now even though operating results are strong; sector rotation away from asset managers hits the P/E before it hits EPS.

• Q3 2026 earnings release in mid-to-late October 2026 — the key read on fee-related earnings growth, fundraising momentum in private wealth channels, and the realization pipeline for the second half.
• Acceleration of the exit/IPO backlog into late 2026 and 2027; any thawing of public-market exits would unlock performance fees and validate the $5.944 next-FY EPS estimate.
• Continued capital return — the quarterly dividend was just raised to $1.29 from $1.16 (+11%), lifting the annualized yield to ~3.9%; further increases or any buyback authorization would be supportive.
• Portfolio activity: reported asset sales (e.g., the Nucleus Network process drawing interest from EQT and Bain) plus fresh deployment into logistics, carve-outs, and AI infrastructure — evidence of the capital-recycling engine working.

• Realization timing is the single biggest risk: a meaningful slice of distributable earnings comes from carried interest, and a closed IPO/M&A window would delay — not destroy — the earnings ramp the market is currently skeptical of.
• Real estate legacy exposure: the recovery is uneven, and slower realizations or fresh impairments in office-exposed funds would hit both earnings and sentiment.
• Corporate leverage: $14.03B of long-term debt against $9.01B of stockholders' equity (D/E 1.556) with a current ratio of 0.918 — structurally normal for an asset manager but thin if fee growth stalls.
• Multiple/valuation risk: at 11.2x book and a 1.56 beta, this stock de-rates violently in risk-off tapes, as it just did (down 32% from its 52-week high of $190.09 even as earnings grew).
• Regulatory scrutiny of private credit, retail evergreen vehicles (BREIT/BXPE-style structures), and carried-interest taxation could pressure both fund flows and the fee economics that underpin the entire valuation.
• Fundraising cyclicality: private-wealth channel inflows slow sharply when public markets are choppy, and that is a direct hit to the highest-multiple part of the franchise.

This is a high-quality franchise trading at a reasonable price with a temporarily broken chart. The engine that matters — fee-related earnings on a growing AUM base — is scaling hard (Q2 2026 revenue +28.5% YoY, diluted EPS +60% YoY, TTM operating margin 52.1%), the dividend just went up 11%, and forward earnings trade at 21.6x against a 5-year average P/E of 40.9x. The honest caveats are equally real: earnings are realization-dependent and the market currently distrusts the timing, the 4.77B/1.57 FMP figures reconcile imperfectly with the company's distributable-earnings framing, and the price is below its 20/50/200-day averages. My read is constructive-but-patient: worth owning at these levels for a long-duration investor, better bought on a reclaim of $133-139 or on an RSI dip below 30 — not a back-up-the-truck moment at $128.51.

Applied a 24x forward P/E to next-FY consensus EPS of $5.944 (24 x 5.944 = $142.66) — a justified discount to Blackstone's own 5-year average P/E of 40.9x (a zero-rate-era figure) and a modest premium to the broad market, warranted by a 52.1% TTM operating margin, 34.8% ROE, 13.6% ROIC, and the mid-to-high-teens distributable earnings growth implied by the two halves of the consensus estimate. Cross-check: the $5.16 annualized dividend ($1.29/quarter) at a 3.6% required yield implies ~$143, which lands on effectively the same number. As of 2026-09-13 that is ~11% above the $128.51 market price and sits between the recent analyst average of $138.29 and the full-consensus $145.89.